Literature DB >> 9698138

Mortality of drug addicts in the United Kingdom 1967-1993.

H Ghodse1, A Oyefeso, B Kilpatrick.   

Abstract

BACKGROUND: Mortality in specified clinical populations has often been regarded as a measure of treatment effectiveness. This study examined time trends in mortality of drug addicts in the UK notified to the Home Office over a 27-year period.
METHODS: The study was a longitudinal analysis of routine mortality data of a population of newly notified addicts from 1967 to 1993. Altogether, 92 802 addicts were newly notified during the study period, and they accounted for 687 673 person-years of observation. The main outcome measures were age-specific all-causes mortality; drug-related mortality; and age- and sex-specific standardized mortality ratios (SMR) 1967-1993.
RESULTS: There were significant differences in death rates between the periods 1967-1976 (19/1000 person-years) and 1984-1993 (10.5/1000 person-years). Excess deaths were significantly higher among the 1967-1976 cohorts than in the 1984-1993 cohorts (SMR ratio = 1.80, 95% CI: 1.64-1.97). The majority of deaths were drug-related, with those aged <45 years more likely to die of a drug-related cause than those older (OR = 6.29, 95% CI: 4.97-7.96).
CONCLUSIONS: It appears that service provision has some impact on all-causes mortality among opiate addicts. As services improved, there was a corresponding decline in mortality rates during the study period. Further preventive measures, however, should be devised to reduce drug-related deaths.

Entities:  

Mesh:

Year:  1998        PMID: 9698138     DOI: 10.1093/ije/27.3.473

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  15 in total

Review 1.  Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS.

Authors:  L Degenhardt; W Hall; M Warner-Smith
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

2.  Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.

Authors:  Ira L Mintzer; Mark Eisenberg; Maria Terra; Casey MacVane; David U Himmelstein; Steffie Woolhandler
Journal:  Ann Fam Med       Date:  2007 Mar-Apr       Impact factor: 5.166

3.  Clinical course of hepatitis C virus during the first decade of infection: cohort study.

Authors:  Helen E Harris; Mary E Ramsay; Nick Andrews; Keith P Eldridge
Journal:  BMJ       Date:  2002-02-23

4.  Drug-related mortality and fatal overdose risk: pilot cohort study of heroin users recruited from specialist drug treatment sites in London.

Authors:  Matthew Hickman; Zenobia Carnwath; Peter Madden; Michael Farrell; Cleone Rooney; Richard Ashcroft; Ali Judd; Gerry Stimson
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

5.  Fatal poisonings in Oslo: a one-year observational study.

Authors:  Mari A Bjornaas; Brita Teige; Knut E Hovda; Oivind Ekeberg; Fridtjof Heyerdahl; Dag Jacobsen
Journal:  BMC Emerg Med       Date:  2010-06-06

6.  Premature mortality among males with substance use disorders.

Authors:  Jack R Cornelius; Maureen Reynolds; Barry M Martz; Duncan B Clark; Levent Kirisci; Ralph Tarter
Journal:  Addict Behav       Date:  2007-05-08       Impact factor: 3.913

7.  Mortality and Return to Work of Drug Abusers From Therapeutic Community Treatment 3 Years After Entry.

Authors:  John E. Berg
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-08

8.  Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation.

Authors:  Boris Sergeev; Andrey Karpets; Anya Sarang; Mikhail Tikhonov
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

9.  Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.

Authors:  Rosie Cornish; John Macleod; John Strang; Peter Vickerman; Matt Hickman
Journal:  BMJ       Date:  2010-10-26

10.  Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970-2006.

Authors:  Anna Nyhlén; Mats Fridell; Martin Bäckström; Morten Hesse; Peter Krantz
Journal:  BMC Psychiatry       Date:  2011-07-30       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.